Potential Risks of KVK-Tech’s Betaxolol Recall
In an alarming announcement, KVK-Tech, Inc., a renowned pharmaceutical company, voluntarily recalled a specific batch of Betaxolol Tablets, USP 10 mg. The FDA promptly echoed this notice on October 3, ensuring the public was informed. The recall, though stemming from the discovery of a single Oxycodone HCl tablet amidst the batch, underscores the pressing concerns regarding quality checks and the possible repercussions for consumers.
The batch in question, labeled 17853A, comprises white, round, film-coated biconvex tablets. Notably, these tablets are embossed with a distinct “K” above the bisecting number “13” on one side while the other side remains plain. Distributed nationally, this batch reached wholesalers and retailers alike. While KVK-Tech has yet to receive reports of any foreign tablets in this specific batch, the potential risk cannot be ignored.
Potential Risks to Consumers
The principal concern revolves around the unintentional administration of opioids. The betaxolol insert specifically warns of a possible decrease in heart rate among the elderly. The addition of an opioid can accentuate this effect. Furthermore, patients on a low dose of betaxolol, especially those with compromised heart and lung functions, may suffer adverse effects if mistakenly given an opioid. With a close resemblance in appearance between the 10 mg betaxolol tablets and the 5 mg oxycodone tablets, regular users might overlook the foreign tablet. Particularly vulnerable are patients with opioid use disorder or those at risk, including infants, children, and the elderly. Accidental consumption could lead to respiratory depression, posing a severe health threat.
Seeking Legal Redress
For victims adversely affected by this lapse, legal avenues exist. Product liability laws hold manufacturers accountable for defects or issues that could harm consumers. Victims can potentially file a lawsuit seeking damages. The potential damages recoverable in a product liability lawsuit encompass:
- Medical Bills: Any medical expenses incurred due to complications or treatment necessary after consuming the defective product.
- Lost Wages: Compensation for any missed work or potential loss of future earnings owing to the injury.
- Pain and Suffering: Damages for physical and mental distress caused by the injury.
- Punitive Damages: In cases where the company’s conduct was particularly egregious, punitive damages might be awarded to punish the company and deter similar behavior in the future.
The legal system provides a framework for victims to seek redress and hold manufacturers accountable for their dangerous products. Whether it’s to cover medical expenses, compensate for lost income, or address the intangible yet profound impacts of pain and suffering, victims have the means to pursue justice. Moreover, punitive damages serve as a stark reminder to all manufacturers about the weight of their responsibility towards consumers and the grave consequences of negligence. In essence, while manufacturers must prioritize product safety and quality, consumers equally must remain vigilant and informed about their rights to ensure accountability.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
If you or someone you know has been affected by this recall or suffered adverse effects after consuming Betaxolol Tablets, USP 10 mg (Batch Number: 17853A), it’s crucial to seek legal counsel immediately. The national product injury law firm, Parker Waichman LLP, is offering a free consultation for victims. With their expertise, you can better understand your rights and potential legal recourse. Act now and call 1-800-YOUR-LAWYER (1-800-968-7529) to ensure you get the justice and compensation you deserve.
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation